Cargando…
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression
Genomic characterization of cancer has enabled identification of numerous molecular targets, which has led to significant advances in personalized medicine. However, with few exceptions, precision medicine approaches in the plasma cell malignancy multiple myeloma (MM) have had limited success, likel...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cold Spring Harbor Laboratory Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240837/ https://www.ncbi.nlm.nih.gov/pubmed/36639200 http://dx.doi.org/10.1101/mcs.a006249 |